Centene Corporation (0HVB.L)
USD 59.81
(-0.08%)
USD 59.81
(-0.08%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 153.99 Billion USD | 13.24% |
| 2022 | 135.99 Billion USD | 15.14% |
| 2021 | 118.11 Billion USD | 13.27% |
| 2020 | 104.28 Billion USD | 47.27% |
| 2019 | 70.8 Billion USD | 24.91% |
| 2018 | 56.68 Billion USD | 23.75% |
| 2017 | 45.81 Billion USD | 21.53% |
| 2016 | 37.69 Billion USD | 77.03% |
| 2015 | 21.29 Billion USD | 35.71% |
| 2014 | 15.68 Billion USD | 48.8% |
| 2013 | 10.54 Billion USD | 36.65% |
| 2012 | 7.71 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 40.4 Billion USD | 2.4% |
| 2024 Q2 | 39.83 Billion USD | -1.41% |
| 2024 Q3 | 42.02 Billion USD | 5.49% |
| 2023 Q3 | 35.18 Billion USD | 0.23% |
| 2023 Q1 | 35.3 Billion USD | 4.52% |
| 2023 FY | 153.99 Billion USD | 13.24% |
| 2023 Q4 | 39.46 Billion USD | 12.16% |
| 2023 Q2 | 35.1 Billion USD | -0.58% |
| 2022 Q2 | 34.01 Billion USD | -0.8% |
| 2022 Q1 | 34.28 Billion USD | 12.28% |
| 2022 Q3 | 33.92 Billion USD | -0.24% |
| 2022 FY | 135.99 Billion USD | 15.14% |
| 2022 Q4 | 33.77 Billion USD | -0.45% |
| 2021 Q3 | 30.4 Billion USD | 4.96% |
| 2021 Q4 | 30.53 Billion USD | 0.44% |
| 2021 FY | 118.11 Billion USD | 13.27% |
| 2021 Q1 | 28.21 Billion USD | 6.28% |
| 2021 Q2 | 28.96 Billion USD | 2.64% |
| 2020 Q2 | 25.83 Billion USD | 6.61% |
| 2020 Q1 | 24.23 Billion USD | 33.61% |
| 2020 Q4 | 26.55 Billion USD | -3.64% |
| 2020 Q3 | 27.55 Billion USD | 6.65% |
| 2020 FY | 104.28 Billion USD | 47.27% |
| 2019 Q2 | 17.41 Billion USD | 2.85% |
| 2019 Q3 | 18.31 Billion USD | 5.13% |
| 2019 FY | 70.8 Billion USD | 24.91% |
| 2019 Q1 | 16.93 Billion USD | 7.77% |
| 2019 Q4 | 18.13 Billion USD | -0.96% |
| 2018 Q2 | 12.94 Billion USD | 2.72% |
| 2018 Q1 | 12.59 Billion USD | 8.17% |
| 2018 Q4 | 15.71 Billion USD | 1.82% |
| 2018 FY | 56.68 Billion USD | 23.75% |
| 2018 Q3 | 15.43 Billion USD | 19.28% |
| 2017 Q4 | 11.64 Billion USD | 1.52% |
| 2017 Q3 | 11.47 Billion USD | -0.12% |
| 2017 Q2 | 11.48 Billion USD | 2.5% |
| 2017 Q1 | 11.2 Billion USD | 4.67% |
| 2017 FY | 45.81 Billion USD | 21.53% |
| 2016 Q4 | 10.7 Billion USD | 4.47% |
| 2016 FY | 37.69 Billion USD | 77.03% |
| 2016 Q3 | 10.24 Billion USD | -0.58% |
| 2016 Q2 | 10.3 Billion USD | 60.41% |
| 2016 Q1 | 6.42 Billion USD | 9.71% |
| 2015 Q2 | 5.19 Billion USD | 8.89% |
| 2015 FY | 21.29 Billion USD | 35.71% |
| 2015 Q1 | 4.77 Billion USD | 7.94% |
| 2015 Q4 | 5.85 Billion USD | 7.06% |
| 2015 Q3 | 5.47 Billion USD | 5.33% |
| 2014 Q2 | 3.74 Billion USD | 11.65% |
| 2014 Q4 | 4.41 Billion USD | 6.1% |
| 2014 Q3 | 4.16 Billion USD | 11.13% |
| 2014 FY | 15.68 Billion USD | 48.8% |
| 2014 Q1 | 3.35 Billion USD | 17.22% |
| 2013 Q1 | 2.42 Billion USD | 38.96% |
| 2013 FY | 10.54 Billion USD | 36.65% |
| 2013 Q3 | 2.73 Billion USD | 8.24% |
| 2013 Q4 | 2.86 Billion USD | 4.87% |
| 2013 Q2 | 2.52 Billion USD | 3.99% |
| 2012 FY | 7.71 Billion USD | 0.0% |
| 2012 Q4 | 1.74 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -76233.49% |
| Accuray Incorporated | 143.12 Million USD | -107500.562% |
| Align Technology, Inc. | 2.72 Billion USD | -5561.389% |
| Elevance Health Inc. | 47.01 Billion USD | -227.588% |
| AxoGen, Inc. | 127.87 Million USD | -120330.267% |
| Boston Scientific Corporation | 9.84 Billion USD | -1463.6% |
| CVS Health Corporation | 54.43 Billion USD | -182.925% |
| Cardinal Health, Inc. | 7.41 Billion USD | -1977.138% |
| DaVita Inc. | 3.82 Billion USD | -3930.934% |
| HCA Healthcare, Inc. | 55.06 Billion USD | -179.663% |
| Hologic, Inc. | 2.23 Billion USD | -6781.714% |
| Humana Inc. | 106.44 Billion USD | -44.682% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -6932.014% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -4476.629% |
| Masimo Corporation | 1 Billion USD | -15246.188% |
| McKesson Corporation | 12.58 Billion USD | -1123.768% |
| Patterson Companies, Inc. | 1.38 Billion USD | -11057.391% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -5100.912% |
| ResMed Inc. | 2.6 Billion USD | -5803.1% |
| Henry Schein, Inc. | 3.65 Billion USD | -4117.995% |
| Teladoc Health, Inc. | 1.84 Billion USD | -8258.681% |
| Universal Health Services, Inc. | 1.17 Billion USD | -13002.049% |
| Veeva Systems Inc. | 1.68 Billion USD | -9031.917% |
| Baxter International Inc. | 4.97 Billion USD | -2995.457% |
| Becton, Dickinson and Company | 8.82 Billion USD | -1645.427% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | -3156.137% |
| Danaher Corporation | 14.12 Billion USD | -989.95% |
| Stryker Corporation | 13.05 Billion USD | -1079.346% |
| Medtronic plc | 21.27 Billion USD | -623.918% |